hiv dna vaccine
Vaccineexperimental
Clinical trial activity
2 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 2004 (NCT00061243)
Timeline
2000s
- Jan 1, 2004
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Human immunodeficiency virusImmunity, active
Human immunodeficiency virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- hiv-1 dna vaccine
- hiv dna vaccine
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01140139 | Phase 1 | Sep 1, 2006 | European Union, Swedish Institute for Infectious Disease Control, The Swedish Research Council |
| NCT00061243 | Phase 1 | Apr 1, 2004 | National Institute of Allergy and Infectious Diseases (NIAID), University of Massachusetts |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| European Union | Government | 1 | 0 | 1 | 2006 |
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 1 | 1 | 1 | 2004 |
| Swedish Institute for Infectious Disease Control | Government | 1 | 1 | 1 | 2006 |
| The Swedish Research Council | Academic/Hospital | 1 | 0 | 1 | 2006 |
| University of Massachusetts | Academic/Hospital | 1 | 0 | 1 | 2004 |
5 organizations
Page 1 / 1